Eosinophilic annular erythema treated with dupilumab

Eosinophilic annular erythema treated with dupilumab

Eosinophilic annular erythema is a rare, benign, recurrent condition characterized by annular skin lesions, tissue eosinophilia, and resistance to a variety of treatments. There are fewer than 30 cases reported in the English literature, 7 of which are in children. We present a case of recurrent eos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric dermatology 2018-07, Vol.35 (4), p.e255-e256
Hauptverfasser: Gordon, Samantha C., Robinson, Sarah N., Abudu, Minawaer, Her, Michelle, Deverapalli, Sandyha, Levin, Adrianne, Schmidt, Birgitta A. R., Gellis, Stephen E., Rosmarin, David
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Antagonist drugs
Antibodies, Monoclonal - therapeutic use
Case reports
Children
Drug resistance
Eosinophilia
Eosinophilia - complications
Eosinophils
Erythema
Erythema - drug therapy
Female
Humans
Immunotherapy
Interleukin-4 Receptor alpha Subunit - antagonists & inhibitors
Leukocytes (eosinophilic)
Monoclonal antibodies
Pediatrics
pharmacology
Skin diseases
Skin Diseases, Genetic - drug therapy
Teenagers
therapy‐systemic
urticaria
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Eosinophilic annular erythema is a rare, benign, recurrent condition characterized by annular skin lesions, tissue eosinophilia, and resistance to a variety of treatments. There are fewer than 30 cases reported in the English literature, 7 of which are in children. We present a case of recurrent eosinophilic annular erythema in an adolescent that was successfully treated with dupilumab, an interleukin‐4 receptor alpha antagonist.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.13533